This is quite different from other histological ovarian cancers such as high-grade serous ovarian carcinomas, in which an ARID1A mutation is relatively rare while p53 mutations are very frequent as essential drivers [3,11,12,31,32,33]. Here, ARID1A is linked to ovarian serous carcinoma.